FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to medical genetics, and is intended for early genetic diagnosis of risk for developing type 2 diabetes mellitus (DM). DNA is extracted from peripheral blood, followed by polymerase chain reaction in real time. Receptor genetic polymorphism to incretin GLP-1R is analyzed. Reduced risk of developing type 2 diabetes is predicted in detecting the genotype GG of polymorphism rs6923761 of the GLP-1R gene.
EFFECT: invention provides an effective diagnosis of a reduced risk of developing type 2 diabetes.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF METABOLIC SYNDROME RISK WITH UNDERLYING ANTIPSYCHOTIC THERAPY IN SCHIZOPHRENIC PATIENTS | 2019 |
|
RU2722649C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING TYPE 2 DIABETES IN RESIDENTS OF CENTRAL RUSSIA BASED ON GENOTYPING OF THE rs755892 POLYMORPHISM OF THE DNAJB1 GENE | 2023 |
|
RU2803637C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING TYPE 2 DIABETES IN RESIDENTS OF CENTRAL RUSSIA BASED ON GENOTYPING OF THE rs11073891 POLYMORPHISM OF THE ANPEP GENE | 2023 |
|
RU2803636C1 |
| METHOD OF EARLY GENETIC DIAGNOSTICS OF RISK FOR DEVELOPING GENITAL ENDOMETRIOSIS | 2017 |
|
RU2676693C1 |
| METHOD OF PREDICTING THE DEVELOPMENT OF SEVERE COURSE OF DISTAL NEUROPATHY AND DIABETIC FOOT SYNDROME IN PATIENTS WITH TYPE 1 AND 2 DIABETES MELLITUS | 2022 |
|
RU2799032C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA IN MEN BASED ON GENETIC DATA | 2021 |
|
RU2775430C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING ESSENTIAL HYPERTENSION | 2017 |
|
RU2661604C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING AN ISCHEMIC STROKE, TAKING INTO ACCOUNT GENETIC AND MEDIUM FACTORS | 2018 |
|
RU2679635C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPMENT OF HYPERTENSIVE DISEASE FACTORED IN GENETIC AND ENVIRONMENTAL FACTORS | 2018 |
|
RU2678441C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING ISCHEMIC STROKE | 2018 |
|
RU2685859C1 |
